These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32855746)

  • 21. Sperm-associated antigen 9 is a promising marker for early diagnosis of endometrial cancer.
    Baser E; Togrul C; Ozgu E; Ayhan S; Caglar M; Erkaya S; Gungor T
    Asian Pac J Cancer Prev; 2013; 14(12):7635-8. PubMed ID: 24460345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum miRNAs panel (miR-16-2*, miR-195, miR-2861, miR-497) as novel non-invasive biomarkers for detection of cervical cancer.
    Zhang Y; Zhang D; Wang F; Xu D; Guo Y; Cui W
    Sci Rep; 2015 Dec; 5():17942. PubMed ID: 26656154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minimum apparent diffusion coefficient for predicting lymphovascular invasion in invasive cervical cancer.
    Yang W; Qiang JW; Tian HP; Chen B; Wang AJ; Zhao JG
    J Magn Reson Imaging; 2017 Jun; 45(6):1771-1779. PubMed ID: 27859961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postreatment squamous cell carcinoma antigen as a survival prognostic factor in patients with locally advanced cervical cancer. A Spanish multicenter study. The SEGO Spain-GOG group.
    Benito V; Lubrano A; Pérez-Regadera JF; Torné A; Gil-Moreno A; Tejerizo-Garcia Á; Vergés R; Díaz-Feijoo B;
    Gynecol Oncol; 2021 Aug; 162(2):407-412. PubMed ID: 34119366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy.
    Gülseren V; Kocaer M; Çakır İ; Özdemir İA; Sancı M; Güngördük K
    J Obstet Gynaecol; 2020 Jul; 40(5):699-704. PubMed ID: 31607197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of immune cell markers and tumor markers in patients with cervical cancer.
    Zhang L; Zhang H; Huang Y; Xi X; Sun Y
    Int J Gynecol Cancer; 2020 Jul; 30(7):969-974. PubMed ID: 32518078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased expression of α-actinin-4 is associated with unfavorable pathological features and invasiveness of bladder cancer.
    Yoshii H; Ito K; Asano T; Horiguchi A; Hayakawa M; Asano T
    Oncol Rep; 2013 Sep; 30(3):1073-80. PubMed ID: 23817592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of eukaryotic initiation factor 5A2 (EIF5A2) is associated with cancer progression and poor prognosis in patients with early-stage cervical cancer.
    Yang SS; Gao Y; Wang DY; Xia BR; Liu YD; Qin Y; Ning XM; Li GY; Hao LX; Xiao M; Zhang YY
    Histopathology; 2016 Aug; 69(2):276-87. PubMed ID: 26799253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Promoter Methylation of Ezrin and its Impact on the Incidence and Prognosis of Cervical Cancer.
    Qin R; Cao L; Wang J; Liu J
    Cell Physiol Biochem; 2018; 50(1):277-287. PubMed ID: 30282070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma.
    Duk JM; Groenier KH; de Bruijn HW; Hollema H; ten Hoor KA; van der Zee AG; Aalders JG
    J Clin Oncol; 1996 Jan; 14(1):111-8. PubMed ID: 8558185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum bradykinin levels as a diagnostic marker in cervical cancer with a potential mechanism to promote VEGF expression via BDKRB2.
    Zhou Y; Wang W; Wei R; Jiang G; Li F; Chen X; Wang X; Long S; Ma D; Xi L
    Int J Oncol; 2019 Jul; 55(1):131-141. PubMed ID: 31059006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A serum lipidomic strategy revealed potential lipid biomarkers for early-stage cervical cancer.
    Cheng F; Wen Z; Feng X; Wang X; Chen Y
    Life Sci; 2020 Nov; 260():118489. PubMed ID: 32976882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Matrix Metalloproteinase-13 - A Potential Biomarker for Detection and Prognostic Assessment of Patients with Esophageal Squamous Cell Carcinoma.
    Sedighi M; Aledavood SA; Abbaszadegan M; Memar B; Montazer M; Rajabian M; Gholamin M
    Asian Pac J Cancer Prev; 2016; 17(6):2781-5. PubMed ID: 27356690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival‑related DLEU1 is associated with HPV infection status and serves as a biomarker in HPV‑infected cervical cancer.
    Dong A; Xu B; Wang Z; Miao X
    Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35014679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripheral platelet/lymphocyte ratio predicts lymph node metastasis and acts as a superior prognostic factor for cervical cancer when combined with neutrophil: Lymphocyte.
    Chen L; Zhang F; Sheng XG; Zhang SQ; Chen YT; Liu BW
    Medicine (Baltimore); 2016 Aug; 95(32):e4381. PubMed ID: 27512849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical significance of serum squamous cell carcinoma antigen in patients with early cervical squamous cell carcinoma].
    Li D; Xu XX; Yan DD; Yuan SH; Lou HM
    Zhonghua Zhong Liu Za Zhi; 2019 May; 41(5):357-362. PubMed ID: 31137169
    [No Abstract]   [Full Text] [Related]  

  • 37. CCT6A may act as a potential biomarker reflecting tumor size, lymphatic metastasis, FIGO stage, and prognosis in cervical cancer patients.
    Ma J; Yang L; Feng H; Zheng L; Meng H; Li X
    J Clin Lab Anal; 2021 Aug; 35(8):e23793. PubMed ID: 34196992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating miRNA-20a and miRNA-203 for screening lymph node metastasis in early stage cervical cancer.
    Zhao S; Yao D; Chen J; Ding N
    Genet Test Mol Biomarkers; 2013 Aug; 17(8):631-6. PubMed ID: 23819812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of serum miR-411 as a diagnosis and prognosis biomarker for non-small cell lung cancer.
    Wang SY; Li Y; Jiang YS; Li RZ
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4092-4097. PubMed ID: 29028091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. WAVE2 is associated with poor prognosis in pancreatic cancers and promotes cell motility and invasiveness via binding to ACTN4.
    Taniuchi K; Furihata M; Naganuma S; Saibara T
    Cancer Med; 2018 Nov; 7(11):5733-5751. PubMed ID: 30353690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.